Viewing nowCombinationJardiance Duo Tablets 12.5/500 mg (Empagliflozin, Metformin)
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.

MFDS item code 202302787 · Approved 2023.09.20 · Insurance code 657808060
Improves glycemic control in adults with type 2 diabetes mellitus
This medication is used to help manage blood sugar in adults with type 2 diabetes who do not receive sufficient blood sugar control with diet and exercise alone. The combination of empagliflozin and metformin enhances blood sugar control and should be used cautiously in patients with cardiovascular disease. This drug helps improve blood sugar levels consistently, aiding in diabetes management.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's existing metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their existing doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; if this occurs, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be closely monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly Patients In patients 75 years of age or older, renal function and the risk of volume depletion should be taken into consideration.
This medication is used for diabetes treatment and contains two active ingredients: empagliflozin and metformin. While taking this medication, there is a risk of developing a rare side effect known as severe lactic acidosis. Lactic acidosis can lead to the accumulation of lactic acid in the body, which can be dangerous, especially in patients with impaired kidney function or those with acute infections, dehydration, or heart problems. Moreover, this medication may cause hypoglycemia (low blood sugar) when used with other diabetes treatments, so careful monitoring of blood sugar levels is necessary. Patients with moderate to severe renal impairment, acute kidney problems, severe liver dysfunction, acute heart failure, type 1 diabetes, or pregnant or breastfeeding women should not use this medication. Before and after the use of iodine contrast for examinations, the intake of this medication should be stopped and resumed only after ensuring normal kidney function. This drug can cause fluid loss, so special caution is required for patients at risk of dehydration or elderly patients undergoing hypertension treatment. During treatment, side effects such as symptoms of hypoglycemia, urinary tract infections, genital infections, increased urination, gastrointestinal disorders (nausea, vomiting, diarrhea, etc.) may occur; if any unusual symptoms arise, consult a doctor immediately. Vitamin B12 levels may decrease, so regular blood tests should be conducted to assess levels and supplementation may be needed. Alcohol consumption may increase the risk of lactic acidosis; hence, avoid excessive drinking during treatment. Elderly patients often have decreased renal function, so renal function tests should be conducted before use and monitored regularly, ensuring not to exceed maximum dosages. In preparation for surgery, the medication should be discontinued 48 hours prior and should be resumed only after a return to normal kidney function post-surgery. This medication is not for use in pregnant women or those who may become pregnant, as well as breastfeeding women. Regular blood tests and renal function checks are required during the treatment, with adjustments to dosage as directed by a physician based on symptoms. Finally, this medication should be kept out of the reach of children and stored in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering. A storage temperature of 1 to 30 degrees Celsius at room temperature is recommended.
Light brownish-purple, biconvex oval film-coated tablet
60 tablets/box [10 tablets/PTP x 6], 30 tablets/bottle, 10 tablets/box [10 tablets/PTP x 1], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.